Midazolam Cholinesterase Experiments Proposed an Epigenetic Link Without Measuring Clinical Delirium

A cellular mechanism hypothesis is not a demonstrated explanation for a patient’s delirium.

What the supplied source reports

The study exposed neural-related cell lines and human peripheral blood cells to midazolam. It measured cholinesterase activity, gene expression and selected epigenetic markers. Changes involving butyrylcholinesterase were associated with methylation-related findings; inflammatory cytokines were not induced under the tested conditions.

Limits and uncertainty

The models did not reproduce an intact perioperative brain or measure delirium in patients. Direct acetylcholine measurement was not performed. Associations among molecular endpoints do not establish that the proposed pathway causes a clinical syndrome.

Implications for forensic review

For expert interpretation, separate the laboratory observation, pathway explanation and patient diagnosis. Delirium has multiple contributors, including illness, other medicines and environmental factors. This study supports a research hypothesis without establishing that midazolam caused delirium through epigenetic change in an individual.

Source and related reading

Source reviewed: Midazolam impacts acetyl And butyrylcholinesterase genes An epigenetic explanation for postoperative (PMC9269431). Forensic applications above are interpretive analysis of the supplied publication.